Fig. 2.

Clinical efficacy of VB-001 in seborrheic dermatitis of the scalp. a Average Adherent Scaling and Flaking Score (ASFS) of patients in ZPTO shampoo group (gray bars; n = 81) and patients in VB-001 group (black bars; n = 78). Values represent group average ± SEM of individual ASFS on each day normalized to their individual score on day 0. Statistical analysis was performed using Student’s t-test [* p < 0.05; ** p < 0.001]. b High resolution scalp images of patients treated with VB-001 (top panel) or antidandruff shampoo containing zinc pyrithione (lower panel) captured using a digital magnascope on the indicated days of the clinical trial